EpiVario

About EpiVario

EpiVario is a biotechnology company focused on innovation, developing neuroepigenetic modulators to treat memory-related addiction and psychiatric disorders. Spun out of the Epigenetics Institute at the University of Pennsylvania, EpiVario pioneers epigenetic therapeutics targeting long-term memory processes to address conditions like PTSD and substance use disorders through novel pharmacotherapies.

Products & Services

Neuroepigenetic Platform:A platform targeting a variety of memory-related psychiatric disorders, starting with nicotine addiction.

ACSS2 Inhibitors:Proprietary small molecule inhibitors targeting ACSS2 to modulate epigenetic processes in long-term memory formation, aimed at treating substance use disorders and PTSD.

Therapies for Psychiatric Disorders:Revolutionary therapies for disorders including Opioid Use Disorder, Alcohol Use Disorder, Nicotine Use Disorder, and Post-Traumatic Stress Disorder, focusing on reducing distress associated with trauma memories.

Specialties

Neuroepigenetics Epigenetic Therapeutics Memory-Related Psychiatric Disorders Substance Use Disorders PTSD Treatment ACSS2 Inhibitors

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: SBIR Grant T: - FT: SBIR Grant	A: 275000 MR: - FA: $275,000 FAN: 275000	D: 2024-10-01 FD: 2024-10-01	1 investors

SBIR Grant Latest

2024-10-01

$275K

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Shelley Berger

Co-Founder and Daniel S. Och University Professor

P

Philipp Mews

Co-Founder and Assistant Professor

C

Chris Cashman

Chairman at MBF Therapeutics, Inc. and Board Member at EpiVario

T

Thomas Kim

President and CEO

E

Eric Schultenover

Corporate Attorney / Entrepreneur

Y

Yi-Yen Chen

Associate Director of PCI Ventures

View 20 more team members with Pro

Unlock Full Team Directory

Recent News

EpiVario Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised